Tagged with

Argentine Ministry of Science ¿Porque fue creado en Ministerio de Ciencia y Tecnología, con que visión? Muchos países están aportando importancia a la ciencia y tecnología y representa la razón del desarrollo económico y social de esos mismos países. El ministerio en Argentina se creó en ese sentido, para ayudar a transformar el conocimiento…

Baxter Germany Next year Baxter will accomplish its 50th anniversary in Germany. In the context of its celebration, what would you highlight as the main achievements of the company especially since you took the reigns of the German operations? Baxter Germany has grown steadily in the German market primarily thanks to its…

G-BA In the last twenty years, Germany has experienced nearly twenty health care reforms. In your opinion, what have been the main reasons for so many changes? The main reason behind two decades of continuous health care reforms is the persistent federal budget restraint. This ultimately meant that an increased number…

Acropolis Associates Could you provide us with an introduction to the company as well as your operations in Shanghai, New York or Singapore? I created Acropolis Associates ten years ago in New York, along with two friends that I met during an Executive MBA program. We entered China in 2004 with operations…

Janssen-Cilag Argentina When we spoke to Javier Lombar of IMS Argentina, he explained that a lot of multinational companies use Argentina as a base for regional operations. How does Janssen-Cilag operate in this Latin American context, and what role does the Argentinean operation play in Janssen-Cilag’s plans? Janssen-Cilag sees the pharmaceutical business…

Your distinguished career in health research leadership and management has seen you through a variety of prestigious positions, not to mention the Order of Australia. Most recently you were appointed as the CEO of the NHMRC in 2006, where you will be until 2011. To begin, would you please introduce…

Ministry of Health Indonesia Overall health indicators have improved significantly in Indonesia in recent years. However, the country still faces many challenges and there are many areas in need of further improvement. What is your assessment on how government policy is contributing toward improved health care in terms of current policies and priorities? Indonesia’s…

Daiichi Sankyo Italy When you became President of Sankyo Pharma Italy in 2003 one of your objectives was to maximize sales of the existing portfolio- and the company’s sales have impressively tripled in this 5 years period. What have been the main guidelines of the Italian operations? Daiichi Sankyo Italy’s ability to brilliantly…

Solvay Pharma Indonesia While the level of sales for pharmaceutical products is plunging in the US and Europe one of the core pillar of Solvay’s strategy is to have a stronger focus on the Asia Pacific region, which for the Pharmaceutical segment represents still less than 9% of the sales. In this respects,…

Grunenthal Italy Grunenthal-Formenti relies on Formenti’s 60 years experience in Italy and is the result of the merger of both the German and Italian entities in 96. How would you describe the process of integrating and combining both cultures to lead an Italo-German company, building on the already existing Italian heritage and…

Korea Food & Drug Administration Please introduce the Korean Food and Drug Administration (KFDA) and its main health-related responsibilities within the Korean government… The KFDA’s main duty is to cooperate and support with domestic and foreign governments, international organizations, research organizations, and related industries to develop safety management system based on the professional knowledge. The…

Mersifarma The Indonesian pharmaceutical market has gone through a series of developing phases which have ultimately led the domestic industry to gain the majority of the market share. In this respect what has been Mersi contribution to the development of the Indonesian pharmaceutical industry? My original vision for the company was…